Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives $55.06 Consensus Target Price from Analysts
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and one has issued a strong buy recommendation on […]
More Stories
Alphabet Inc. (NASDAQ:GOOGL) Shares Acquired by Philip James Wealth Mangement LLC
Philip James Wealth Mangement LLC grew its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 82.9% during the first...
Bull Street Advisors LLC Reduces Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Bull Street Advisors LLC decreased its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.7% during the...
Hartmann Taylor Wealth Management LLC Acquires Shares of 2,577 Alphabet Inc. (NASDAQ:GOOGL)
Hartmann Taylor Wealth Management LLC bought a new stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) in the...
Waverton Investment Management Ltd Increases Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Waverton Investment Management Ltd raised its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 7.0% during the...
Canvas Wealth Advisors LLC Purchases 19,872 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Canvas Wealth Advisors LLC boosted its position in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 22.3% during the...
Mirae Asset Global Investments Co. Ltd. Makes New Investment in Expand Energy Corporation (NASDAQ:EXE)
Mirae Asset Global Investments Co. Ltd. purchased a new stake in Expand Energy Corporation (NASDAQ:EXE – Free Report) during the...